Neoleukin Therapeutics EV - Enterprise Value 2011-2025 | NLTX

Annual EV - Enterprise Value Neoleukin Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-110 M	-33.8 M	19.9 M	509 M	180 M	-19.3 M	264 M	311 M	98 M	82.3 M	-6.12 M	51.4 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
509 M	-110 M	112 M

EV - Enterprise Value of other stocks in the Drug manufacturers industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	197 M	-	-	$ 142 M	USA
Assertio Holdings ASRT	141 M	$ 0.74	-3.53 %	$ 52.6 M	USA
Aerie Pharmaceuticals AERI	737 M	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	459 M	$ 1.69	-3.13 %	$ 182 M	Canada
AcelRx Pharmaceuticals ACRX	23.6 M	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	28.5 M	-	0.86 %	$ 117 M	USA
Cronos Group CRON	3.84 B	$ 3.06	-6.57 %	$ 1.61 B	Canada
Agile Therapeutics AGRX	25.3 M	-	10.11 %	$ 58.2 M	USA
Aurora Cannabis ACB	106 M	$ 5.18	-4.17 %	$ 86.3 M	Canada
Catalent CTLT	16.7 B	-	-	$ 11.5 B	USA
Calliditas Therapeutics AB (publ) CALT	10.2 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	284 M	-	2.45 %	$ 38.1 M	Canada
DURECT Corporation DRRX	3.37 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	457 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	-710 M	-	-	$ 28.9 M	Irlanda
Emergent BioSolutions EBS	1.2 B	$ 11.76	2.98 %	$ 602 M	USA
Evoke Pharma EVOK	7.15 M	$ 10.97	0.18 %	$ 36.7 M	USA
Athenex ATNX	209 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	756 M	$ 21.39	0.14 %	$ 2.04 B	France
Evolus EOLS	1.03 B	$ 7.17	1.85 %	$ 445 M	USA
Harrow Health HROW	515 M	$ 46.47	-1.25 %	$ 1.52 B	USA
China Pharma Holdings CPHI	11.1 M	$ 1.55	-0.64 %	$ 27.1 M	China
Bausch Health Companies BHC	29.9 B	$ 6.83	-1.37 %	$ 2.49 B	Canada
Lannett Company LCI	648 M	-	1.15 %	$ 7.11 M	USA
Organogenesis Holdings ORGO	392 M	$ 4.86	0.73 %	$ 640 M	USA
OrganiGram Holdings OGI	456 M	$ 1.82	-5.36 %	$ 402 M	Canada
Cumberland Pharmaceuticals CPIX	124 M	$ 3.03	19.57 %	$ 42.6 M	USA
Pacira BioSciences PCRX	1.68 B	$ 26.71	1.6 %	$ 1.24 B	USA
Rockwell Medical RMTI	57.3 M	$ 0.88	-5.09 %	$ 20.5 M	USA
Solid Biosciences SLDB	197 M	$ 5.81	-1.02 %	$ 237 M	USA
Sonoma Pharmaceuticals SNOA	7.57 M	$ 3.45	-3.96 %	$ 4.28 M	USA
PetIQ PETQ	280 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	170 M	$ 4.32	6.4 %	$ 130 M	USA
Jupiter Wellness JUPW	91.9 M	-	-	$ 33.6 M	USA
Perrigo Company plc PRGO	8.73 B	$ 12.85	-2.17 %	$ 1.77 B	USA
ProPhase Labs PRPH	145 M	$ 0.11	-2.7 %	$ 1.74 M	USA
Radius Health RDUS	700 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	220 M	-	-4.76 %	$ 65.3 M	USA
Sundial Growers SNDL	-2.47 M	$ 2.02	-8.68 %	$ 3.37 M	Canada
OptiNose OPTN	312 M	-	-	$ 1.08 B	USA
Veru VERU	111 M	$ 2.43	0.41 %	$ 328 M	USA
PLx Pharma PLXP	73.8 M	-	-27.8 %	$ 2.56 M	USA
cbdMD YCBD	7.85 M	$ 1.4	14.75 %	$ 6.04 M	USA
SCYNEXIS SCYX	91.7 M	$ 0.64	-1.21 %	$ 30.6 M	USA
Tricida TCDA	506 M	-	-	$ 3.25 M	USA
Tilray TLRY	1.96 B	$ 11.41	-6.09 %	$ 7.05 B	Canada
TherapeuticsMD TXMD	33.6 M	$ 1.69	-3.43 %	$ 17.6 M	USA
Zomedica Corp. ZOM	137 M	-	-0.21 %	$ 98 M	USA
Viatris VTRS	41.3 B	$ 11.68	0.21 %	$ 14.2 B	USA